The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertility

Turku University Central Hospital0 个研究点目标入组 80 人开始时间: 2022年9月9日最近更新: 2024年7月22日

试验速览

暂无简介。

•Females -Age 20 – 37 year -Mild or moderate endometriosis either diagnosed by surgery or ultrasound or strong clinical suspicion of peritoneal endometriosis based on NICE Guidelines -Endometriosis related pain NRS > 3 (dysmenorrhea) -Primary or secondary infertility for 1 year or more -Cause of infertility: mild or moderate endometriosis, unknown ‘ -Regular ovulatory cycles

•-Body mass index more than 35 kg/m2 or less than 18 kg/m2 -Severe endometriosis defined as o> 4 cm unilateral endometrioma or bilateral endometriomas oAdhesions above the level of sacrouterine ligaments demonstrated by absent sliding sign in ultrasound examination or detected surgically oDeep invasive endometriosis of bowel -Hormonal suppression of endometriosis or hormonal contraception within 6 mo -Other diagnosed cause of infertility oOvulatory dysfunction oTubal factor (Tubal occlusion, hydrosalpinx, tubal sterilization) oUterine factor (Submucous myoma, intramural myoma > 4 cm, Uterine malformation apart from Uterus arcuatus) oMale factor oSocial infertility -Indication for IVF-treatment -Hyperprolactinemia, macroprolactinemia excluded -Unbalanced hypothyreoidism -Cardiac disorders -Pleural, pericardiac or retroperinoteal fibrosis -Liver dysfunction -Clinical depression or other phychiatric disorder -Previous malignancy -Allergy for cabergoline -Insufficient skills in Finnish, Swedish or English language

发起方

Turku University Central Hospital